Drug profile · INN
padeliporfin
TOOKAD
padeliporfin (TOOKAD) is an FDA-listed pharmaceutical active ingredient.
EMA: approved Antineoplastic and immunomodulating agents (L01) L01XD07
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — padeliporfin
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
padeliporfin (TOOKAD) is an FDA-listed pharmaceutical active ingredient.
Key facts
INN padeliporfin
Brand TOOKAD
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XD07
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is padeliporfin?
padeliporfin (TOOKAD) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for padeliporfin?
TOOKAD is a marketed brand name for padeliporfin. Check FDA Drugs@FDA for the current US label holder and prescribing information.